As announced by National Health and Medical Research Council (NHMRC) CEO Professor Anne Kelso on 5 April, the reaccreditation will enable MACH to continue its work to improve healthcare in Australia.
“This endorsement is thanks to the excellent work of MACH’s partners in bringing new innovations in healthcare to the public,” says MACH Executive Director Professor Sir John Savill.
“There have been a remarkable number of achievements over the last several years, which is particularly notable in such a challenging environment.
“I’m delighted that we can continue to nurture the future leaders of healthcare in Australia and support world-leading research to strengthen our health systems.”
The NHMRC established the Research Translation Centre Initiative in 2014 to encourage leadership in excellent health research and translation by bringing together researchers, healthcare providers and educators to improve the health and wellbeing of patients.
MACH was originally accredited in 2015. The criteria for accreditation include translating research findings into benefits for patients, developing excellence in innovative health research and building capacity through education and training.
The NHMRC’s reaccreditation process considers both what a Research Translation Centre has achieved, as well as its future potential.
Professor Jane Gunn, the Dean of the University of Melbourne’s Faculty of Medicine, Dentistry and Health Sciences and Chair of the MACH Board, says MACH will now continue its vital work for the benefit of the community and the health system.
“MACH demonstrates the power of effective collaboration.
“By coming together to nurture people across our networks and support innovative ideas, our impact surpasses what any one organisation can achieve in isolation, leading to better outcomes for patients in our state, the nation and globally,” says Professor Gunn.